AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Historical Holders from Q1 2023 to Q3 2025

Symbol: AVDL on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 96,489,844
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 79,016,909
Holdings value: $1,206,598,155
% of all portfolios: 0.005%
Number of holders: 181
Number of buys: 91
Number of sells: -77
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
JANUS HENDERSON GROUP PLC	7.7%	-31.7%	$113,451,794	-$56,535,847	7,429,718	-33.3%	JANUS HENDERSON GROUP PLC	30 Sep 2025
BlackRock, Inc.	7%		$59,674,993		6,742,480		BlackRock, Inc.	30 Jun 2025
Two Seas Capital LP	6.4%	+26%	$60,135,073	+$11,808,266	6,155,074	+24.4%	Two Seas Capital LP	30 Jun 2025
BRANDES INVESTMENT PARTNERS, LP	5.9%		$49,731,881		5,670,682		BRANDES INVESTMENT PARTNERS, LP	31 Mar 2025
VANGUARD GROUP INC	5.74%		$49,243,692		5,564,259		The Vanguard Group	30 Jun 2025

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	79,016,909	$1,206,598,155	-$18,919,297	$17,012,307	$28,022,965	$15.27	181
2025 Q2	80,502,710	$712,425,370	+$33,247,786	$3,501,060	$762,870	$8.85	166
2025 Q1	77,015,539	$605,345,850	-$36,026,238	$3,357,207	$1,817,478	$7.83	169
2024 Q4	78,709,574	$827,347,590	+$46,727,000	$10,204,159	$21,480,126	$10.51	153
2024 Q3	73,371,084	$962,302,695	+$83,134,728	$42,743,562	$30,148,754	$13.12	169
2024 Q2	66,234,240	$931,472,460	+$905,737,723	$10,642,014	$19,236,892	$14.06	142
2024 Q1	1,624,846	$27,443,649	+$27,443,649			$16.89	7
2023 Q2	0	$0	-$4,287				0
2023 Q1	468	$4,287	+$4,287			$9.16	1